Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4402)
All Articles published online
|
Apr 21, 2010 (publication date) through Nov 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T. Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer. World J Gastroenterol 2010; 16(15): 1854-1858 [PMID: 20397262 DOI: 10.3748/wjg.v16.i15.1854] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i15/1854.htm |
| Number | Citing Articles |
| 1 |
Henu Kumar Verma, L. V. K. S. Bhaskar. Exploring Pancreatic Metabolism and Malignancy. 2019; : 197 doi: 10.1007/978-981-32-9393-9_12
|
| 2 |
Xiaoqun Dong, Yanan Li, Hongwei Tang, Ping Chang, Kenneth R. Hess, James L. Abbruzzese, Donghui Li. Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Cancer Epidemiology 2012; 36(2): 206 doi: 10.1016/j.canep.2011.05.013
|
| 3 |
Matias E. Valsecchi, Mary McDonald, Jonathan R. Brody, Terry Hyslop, Boris Freydin, Charles J. Yeo, Charalambos Solomides, Stephen C. Peiper, Agnieszka K. Witkiewicz. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma. Cancer 2012; 118(14): 3484 doi: 10.1002/cncr.26661
|
| 4 |
Nikolaos Ioannou, Alan M Seddon, Angus Dalgleish, David Mackintosh, Helmout Modjtahedi. Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells. BMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-41
|
| 5 |
Sara Chiblak, Kenneth E. Lipson, Amir Abdollahi. Molecular Diagnostics and Treatment of Pancreatic Cancer. 2014; : 39 doi: 10.1016/B978-0-12-408103-1.00003-0
|
| 6 |
Deeksha Vishwamitra, Suraj Konnath George, Ping Shi, Ahmed O. Kaseb, Hesham M. Amin. Type I insulin-like growth factor receptor signaling in hematological malignancies. Oncotarget 2017; 8(1): 1814 doi: 10.18632/oncotarget.12123
|
| 7 |
Minoru Tomizawa, Fuminobu Shinozaki, Takao Sugiyama, Shigenori Yamamoto, Makoto Sueishi, Takanobu Yoshida. Insulin‐Like growth factor I receptor involvement in proliferation of NOR‐P1 cells in serum‐free media. Journal of Cellular Biochemistry 2012; 113(8): 2714 doi: 10.1002/jcb.24149
|
| 8 |
Amir Hossein Daneshmanesh, Mohammad Hojjat-Farsangi, Amineh Ghaderi, Ali Moshfegh, Lotta Hansson, Johan Schultz, Jan Vågberg, Styrbjörn Byström, Elisabeth Olsson, Thomas Olin, Anders Österborg, Håkan Mellstedt, Aamir Ahmad. A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib. PLOS ONE 2018; 13(6): e0198038 doi: 10.1371/journal.pone.0198038
|
| 9 |
Marija Trajkovic-Arsic, Evdokia Kalideris, Jens T Siveke. The role of insulin and IGF system in pancreatic cancer. Journal of Molecular Endocrinology 2013; 50(3): R67 doi: 10.1530/JME-12-0259
|
| 10 |
David T. Chao, Nilesh H. Shah, Herbert J. Zeh, Nathan Bahary, David C. Whitcomb, Randall E. Brand. Increased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus. Pancreas 2016; 45(2): 228 doi: 10.1097/MPA.0000000000000439
|
| 11 |
Daoming Liang, Yi Zhang, Jiayong Chen, Hua Wang, Tao Huang, Xin Xue. Effects of Exogenous Growth Hormone on Growth Hormone-Insulin-Like Growth Factor Axis of Human Gastric Cancer Cell. Chinese Medicine 2014; 5(04): 259 doi: 10.4236/cm.2014.54031
|
| 12 |
F. Huguet, M. Fernet, L. Monnier, E. Touboul, V. Favaudon. Mécanismes de carcinogenèse des cancers du pancréas : quelles pistes pour la radiosensibilisation ?. Cancer/Radiothérapie 2011; 15(5): 365 doi: 10.1016/j.canrad.2011.04.001
|
| 13 |
Changyi Chen. Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicine. Medical Science Monitor 2013; 19: 916 doi: 10.12659/MSM.889636
|
| 14 |
Chao-Feng Chang, Yu-Chen Tseng, Hsin-Hung Huang, Yu-Lueng Shih, Tsai-Yuan Hsieh, Hsuan-Hwai Lin. Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey. Internal and Emergency Medicine 2018; 13(2): 191 doi: 10.1007/s11739-017-1774-x
|
| 15 |
Maciej Tarnowski, Marta Tkacz, Katarzyna Zgutka, Joanna Bujak, Patrycja Kopytko, Andrzej Pawlik. Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3495-y
|
| 16 |
Estefania Carrasco-Garcia, Isabel Martinez-Lacaci, Leticia Mayor-López, Elena Tristante, Mar Carballo-Santana, Pilar García-Morales, Maria Paz Ventero Martin, Maria Fuentes-Baile, Álvaro Rodriguez-Lescure, Miguel Saceda. PDGFR and IGF-1R Inhibitors Induce a G2/M Arrest and Subsequent Cell Death in Human Glioblastoma Cell Lines. Cells 2018; 7(9): 131 doi: 10.3390/cells7090131
|
| 17 |
Leonardo Bernal, Luca Pinzi, Giulio Rastelli. Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing. International Journal of Molecular Sciences 2023; 24(4): 3135 doi: 10.3390/ijms24043135
|
| 18 |
Suzanne L Doyle, Claire L Donohoe, Stephen P Finn, Julia M Howard, Fiona E Lithander, John V Reynolds, Graham P Pidgeon, Joanne Lysaght. IGF-1 and Its Receptor in Esophageal Cancer: Association with Adenocarcinoma and Visceral Obesity. American Journal of Gastroenterology 2012; 107(2): 196 doi: 10.1038/ajg.2011.417
|
| 19 |
Hui Zhao, Vidhi Desai, Jian Wang, David M. Epstein, Mark Miglarese, Elizabeth Buck. Epithelial–Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines. Molecular Cancer Therapeutics 2012; 11(2): 503 doi: 10.1158/1535-7163.MCT-11-0327
|
| 20 |
Barbara Wlodarczyk, Anita Gasiorowska, Anna Borkowska, Ewa Malecka-Panas. Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC). Pancreatology 2017; 17(4): 623 doi: 10.1016/j.pan.2017.04.001
|
| 21 |
Joseph A. Ludwig, Salah-Eddine Lamhamedi-Cherradi, Ho-Young Lee, Aung Naing, Robert Benjamin. Dual Targeting of the Insulin-Like Growth Factor and Collateral Pathways in Cancer: Combating Drug Resistance. Cancers 2011; 3(3): 3029 doi: 10.3390/cancers3033029
|
| 22 |
Kaye M. Reid-Lombardo, Brooke L. Fridley, William R. Bamlet, Julie M. Cunningham, Michael G. Sarr, Gloria M. Petersen. Survival Is Associated With Genetic Variation in Inflammatory Pathway Genes Among Patients With Resected and Unresected Pancreatic Cancer. Annals of Surgery 2013; 257(6): 1096 doi: 10.1097/SLA.0b013e318275b7e5
|
| 23 |
Romain Baer, Célia Cintas, Nicole Therville, Julie Guillermet-Guibert. Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?. Advances in Biological Regulation 2015; 59: 19 doi: 10.1016/j.jbior.2015.05.001
|
| 24 |
Rosalyn D. Ferguson, Nyosha Alikhani, Archana Vijayakumar, Yvonne Fierz, Dara Cannata, Shoshana Yakar. Insulin-like Growth Factors and Cancer. 2012; : 105 doi: 10.1007/978-1-4614-0598-6_6
|
| 25 |
Barbara Wlodarczyk, Anita Gasiorowska, Ewa Malecka-Panas. The Role of Insulin-like Growth Factor (IGF) Axis in Early Diagnosis of Pancreatic Adenocarcinoma (PDAC). Journal of Clinical Gastroenterology 2018; 52(7): 569 doi: 10.1097/MCG.0000000000001073
|
| 26 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, MAKOTO SUEISHI, TAKANOBU YOSHIDA. Frizzled-2: A potential novel target for molecular pancreatic cancer therapy. Oncology Letters 2014; 7(1): 74 doi: 10.3892/ol.2013.1681
|
| 27 |
Chen Sun, Ann H. Rosendahl, Roland Andersson, DeQuan Wu, Xiangdong Wang. The Role of Phosphatidylinositol 3-Kinase Signaling Pathways in Pancreatic Cancer. Pancreatology 2011; 11(2): 252 doi: 10.1159/000327715
|
| 28 |
WEN-ZHOU DING, QING-FENG NI, YE-TING LU, LIANG-LIANG KONG, JIAN-JUN YU, LONG-WEI TAN, LIAN-BAO KONG. MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma. Oncology Letters 2016; 11(2): 1081 doi: 10.3892/ol.2015.3981
|
| 29 |
Ramadevi Subramani, Rebecca Lopez-Valdez, Arunkumar Arumugam, Sushmita Nandy, Thiyagarajan Boopalan, Rajkumar Lakshmanaswamy, Lucia R. Languino. Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis. PLoS ONE 2014; 9(5): e97016 doi: 10.1371/journal.pone.0097016
|
| 30 |
Qi Zhang, Jing Pan, Ronald A. Lubet, Yian Wang, Ming You. Targeting the insulin‐like growth factor‐1 receptor by picropodophyllin for lung cancer chemoprevention. Molecular Carcinogenesis 2015; 54(S1) doi: 10.1002/mc.22206
|
| 31 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. SU11274 suppresses proliferation and motility of pancreatic cancer cells. Oncology Letters 2015; 10(3): 1468 doi: 10.3892/ol.2015.3452
|
| 32 |
Shady Sapoor, Mahmoud Nageh, Noran Magdy Shalma, Rana Sharaf, Nooran Haroun, Esraa Salama, Tungki Pratama Umar, Sadish Sharma, Reem Sayad. Bidirectional relationship between pancreatic cancer and diabetes mellitus: a comprehensive literature review. Annals of Medicine & Surgery 2024; doi: 10.1097/MS9.0000000000002036
|